Impact of the number of cycles of platinum-based first-line chemotherapy for advanced urothelial carcinoma.
J Urol. 2018 Jul 13;:
N Engl J Med. 2018 Jun 13;:
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.
World J Urol. 2018 Jun 07;:
The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.
Bladder Cancer. 2018 Apr 26;4(2):185-194
Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel.
Can Urol Assoc J. 2018 Apr 06;:
Cancer. 2018 Apr 06;:
Improving patient journey and quality of care: Summary from the 2nd Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.
Can Urol Assoc J. 2018 Mar 19;:
The Bladder Utility Symptom Scale (BUSS): A Novel Patient-Reported Outcome Instrument in Bladder Cancer.
J Urol. 2018 Mar 09;:
Clin Genitourin Cancer. 2017 Dec 06;:
Curr Oncol. 2017 Dec;24(6):e494-e502